FIELD: chemistry.
SUBSTANCE: invention relates to novel compounds of formulae Ia, Ic, Ig, Ik and pharmaceutically acceptable salts thereof, having activity towards cannabinoid 1 receptor. In formulae
, 
,
, 
,
R2 is selected from halogen, pyrazinyl, pyridazinyl, pyrimidinyl, pyridinyl, pyridinyl-N-oxide and phenyl; where the said pyrimidinyl, pyridinyl, pyridinyl-N-oxide, pyrazinyl and phenyl are optionally substituted with an amino group; R3 is selected from hydrogen, methylsulphonyl, methlsulphoxide and dimethylaminocarbonyl; R4 is selected from hydrogen, cyano, nitro, carbamimidoyl, tetrazolyl, aminosulphonyl, aminocarbonyl, methylsulphonylamino and methylsulphonyl; R6 is selected from hydrogen, hydroxyethylaminomethyl and methylsulphonylaminomethyl. The invention also relates to a pharmaceutical composition, methods of treating and preventing diseases mediated by the cannabinoid 1 receptor, and use of said compounds in preparing a medicinal agent used to treat such diseases.
EFFECT: improved properties of the derivatives.
12 cl, 1 tbl, 62 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS AND COMPOSITIONS AS CANNABINOID RECEPTOR 1 INHIBITORS | 2005 |
|
RU2431635C2 |
| HETEROARYL-SUBSTITUTED PIPERIDINE DERIVATIVES AS HEPATIC CARNITINE PALMITOYLTRANSFERASE (L-CPT1) INHIBITORS | 2006 |
|
RU2396269C2 |
| HETEROCYCLIC INHIBITORS OF Hh-SYGNAL CASCADE, BASED ON THEM MEDICINAL COMPOSITIONS AND METHOD OF TREATING DISEASES INDUCED BY ABBARANT ACTIVITY OF Hh-SIGNAL SYSTEM | 2007 |
|
RU2364597C1 |
| THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2180659C2 |
| HERBICIDE COMPOSITIONS | 2007 |
|
RU2472343C9 |
| MKK4 PROTEIN KINASE INHIBITORS FOR STIMULATION OF LIVER REGENERATION OR REDUCTION OR PREVENTION OF HEPATOCYTE DEATH | 2019 |
|
RU2788000C2 |
| DERIVATIVES OF 4,5-DIHYDRO-1H-PYRAZOLE POSSESSING CB-ANTAGONISTIC ACTIVITY | 2002 |
|
RU2281941C2 |
| COMPOSITIONS CONTAINING BENZOPIPERAZINE AS BROMODOMAIN BET INHIBITORS | 2014 |
|
RU2720237C2 |
| PYRAZOLE QUINOLINONE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC APPLICATION | 2012 |
|
RU2621037C2 |
| CIS-2,4,5-TRIARYLIMIDAZOLINES AND USE THEREOF AS ANTICANCER MEDICINAL AGENTS | 2006 |
|
RU2411238C2 |
